4//SEC Filing
Wells David R. 4
Accession 0001209191-21-002370
CIK 0001681682other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:15 PM ET
Size
7.2 KB
Accession
0001209191-21-002370
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-01-06$0.90/sh−34,900$31,410→ 80,003 total - Sale
Common Stock
2021-01-05$0.90/sh−100$90→ 114,903 total
Holdings
- 24,786(indirect: By StoryCorp Consulting)
Common Stock
Footnotes (1)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan in order to pay the tax liability associated with the vesting of restricted stock units which were granted to the Reporting Person on April 9, 2020.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001480371
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:15 PM ET
- Size
- 7.2 KB